M. Mastropasqua

发表

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Harald Frick, Joachim Diebold, Mauro G. Mastropasqua, 2012, PloS one.

An international Ki67 reproducibility study.

John M S Bartlett, Mitch Dowsett, Lisa M McShane, 2013, Journal of the National Cancer Institute.

Outcome of special types of luminal breast cancer.

A. Luini, A. Goldhirsch, G. Pruneri, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy

G. Pruneri, G. Viale, E. Maiorano, 2005, Annals of surgery.

Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast

G. Pruneri, G. Viale, E. Maiorano, 2005, Modern Pathology.

Ectopic Breast Tissue as a Possible Cause of False-Positive Axillary Sentinel Lymph Node Biopsies

G. Pruneri, G. Viale, E. Maiorano, 2003, The American journal of surgical pathology.

Male breast cancer.

B. Bonanni, P. Arnone, M. Mastropasqua, 2010, Future oncology.

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

R. Gelber, L. Mazzucchelli, B. Gusterson, 2006, Journal of the National Cancer Institute.

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

A. Goldhirsch, G. Viale, M. Mastropasqua, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

M. Piccart, M. Gnant, A. Goldhirsch, 2015, European journal of cancer.

Primary and secondary angiosarcomas of the breast: a single institution experience

A. Luini, G. Viale, H. Gobbi, 2012, Breast Cancer Research and Treatment.

Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies

G. Viale, M. Mastropasqua, Mauro G Mastropasqua, 2010, Current opinion in oncology.

Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma

D. Ribatti, V. Longo, R. Tamma, 2019, European journal of clinical investigation.

Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

A. Giobbie-Hurder, P. Neven, A. Goldhirsch, 2009 .

Clinical Investigation : Breast Cancer How Do the ASTRO Consensus Statement Guidelines for the Application of Accelerated Partial Breast Irradiation Fit Intraoperative Radiotherapy ? A Retrospective Analysis of Patients Treated at the European Institute of Oncology

A. Luini, U. Veronesi, R. Orecchia, 2022 .

Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection.

A. Luini, U. Veronesi, R. Orecchia, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

A. Luini, A. Goldhirsch, G. Viale, 2015, Clinical breast cancer.

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).

M. Mastropasqua, S. Monti, V. Galimberti, 2013, Breast.

Paget’s Disease as a Local Recurrence after Nipple-Sparing Mastectomy: Clinical Presentation, Treatment, Outcome, and Risk Factor Analysis

M. Mastropasqua, A. Manconi, E. Botteri, 2012, Annals of Surgical Oncology.

Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement

G. Botti, G. Viale, L. Gianni, 2021, Tumori.

Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate?

M. Mastropasqua, A. Bozzini, G. Mazzarol, 2021, Diagnostics.

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

A. Gown, S. Leung, T. Nielsen, 2022, Modern Pathology.

A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit

M. Mastropasqua, G. Tomasicchio, A. Picciariello, 2022, Cancers.

Wireless ultrasound‐guided vacuum‐assisted breast biopsy: Experience in clinical practice at European Institute of Oncology

M. Mastropasqua, A. Bozzini, G. Renne, 2021, The breast journal.

Early studies establishing the predictive and prognostic value of steroid hormone receptors measured levels of ER and PgR in Background: Tumor levels of steroid hormone receptors, a factor used to select adjuvant treatment for early-stage breast

R. Gelber, L. Mazzucchelli, B. Gusterson, 2006 .

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.

A. Luini, A. Goldhirsch, G. Pruneri, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes

O. Garrone, M. Mastropasqua, N. Fusco, 2022, Life.

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

A. Luini, A. Goldhirsch, G. Pruneri, 2014, Breast Cancer Research.

When Histological Tumor Type Diagnosed on Core Biopsy Changes Its Face after Surgery: Report of a Deceptive Case of Breast Carcinoma

M. Mastropasqua, G. Tomasicchio, Giovanna Giliberti, 2022, Reports.

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy

R. Gelber, A. Goldhirsch, G. Viale, 2010, Breast Cancer Research and Treatment.

Renal Cell Carcinoma Intravascular Spread Into Segmental Branches of the Renal Vein: A Single Institution Case Series

G. Ingravallo, M. Battaglia, E. Maiorano, 2021 .

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

A. Luini, A. Goldhirsch, G. Pruneri, 2010, Breast Cancer Research and Treatment.

Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases

G. Ingravallo, E. Maiorano, M. Mastropasqua, 2020, Journal of clinical medicine.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

A. Luini, R. Gelber, A. Goldhirsch, 2013, The Lancet. Oncology.

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism

D. Ribatti, S. Calza, E. Maiorano, 2020, Cancer Research.

Abstract P1-01-01: Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration

John M S Bartlett, Indu Arun, Mitch Dowsett, 2016 .

Advances and controversies in management of breast ductal carcinoma in situ (DCIS).

B. Bonanni, G. Viale, G. Curigliano, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report.

B. Djavan, M. Mastropasqua, O. de Cobelli, 2006, European urology.

Basaloid cell carcinoma of the prostate. Case report and review of the literature

G. Pruneri, G. Viale, M. Mastropasqua, 2003, Virchows Archiv.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

A. Giobbie-Hurder, P. Neven, R. Gelber, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

COVID‐19 and breast fine needle aspiration cytology method: What should we change?

M. Mastropasqua, A. Bozzini, L. Nicosia, 2021, Cytopathology : official journal of the British Society for Clinical Cytology.

An international study to increase concordance in Ki67 scoring

John M S Bartlett, Mitch Dowsett, Lisa M McShane, 2015, Modern Pathology.

MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome

P. Ditonno, M. Battaglia, E. Maiorano, 2022, International journal of molecular sciences.

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

A. Luini, A. Goldhirsch, G. Pruneri, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

A. Luini, A. Goldhirsch, G. Pruneri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

A. Luini, A. Goldhirsch, G. Pruneri, 2013, Clinical breast cancer.

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2008, Journal of the National Cancer Institute.

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

R. Gelber, B. Gusterson, A. Goldhirsch, 2008, The Lancet. Oncology.

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

P. Neven, R. Gelber, B. Gusterson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial

P. Fasching, C. Denkert, M. Dietel, 2019, Breast Cancer Research and Treatment.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration

Tomoharu Sugie, Indu Arun, Mitch Dowsett, 2019, Histopathology.

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation

A. Luini, A. Goldhirsch, G. Viale, 2011, Breast Cancer Research and Treatment.

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer : BIG 198

P. Neven, R. Gelber, B. Gusterson, 2007 .

Breast Cancer Pathology

M. Mastropasqua, 2013 .

The central role of pathology labs in breast cancer precision oncology: a call for action

G. Pruneri, A. Sapino, D. Santini, 2023, npj Breast Cancer.

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

R. Gelber, B. Gusterson, A. Goldhirsch, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

A. Luini, A. Goldhirsch, G. Pruneri, 2011, Breast Cancer Research and Treatment.

Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation

D. Ribatti, R. Tamma, E. Maiorano, 2018, Annals of Hematology.

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature

G. Ingravallo, E. Maiorano, M. Mastropasqua, 2020, Journal of clinical medicine.

Robotic vs open prostatectomy in a laparoscopically naive centre: a matched‐pair analysis

L. Santoro, M. Mastropasqua, S. Detti, 2009, BJU international.

β3 adrenergic receptor as potential therapeutic target in ADPKD

F. Schena, M. Caplan, E. Maiorano, 2021, Physiological reports.

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study

G. Pruneri, A. Vingiani, P. Maisonneuve, 2020, Breast Cancer Research and Treatment.

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

A. Luini, A. Goldhirsch, G. Viale, 2010, European journal of cancer.

Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience

G. Viale, E. Maiorano, M. Mastropasqua, 2006, Virchows Archiv.

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution

B. Bonanni, L. Mariani, A. Goldhirsch, 2004, Cancer.

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer

A. Luini, A. Goldhirsch, G. Viale, 2012, Breast Cancer Research and Treatment.

Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ

G. Di Giulio, A. Rotili, M. Mastropasqua, 2021, Cancers.

Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.

G. Viale, R. Orecchia, P. Maisonneuve, 2017, International journal of radiation oncology, biology, physics.

Metastatic Tumors of the Oro-Facial Tissues: Clear Cell Renal Cell Carcinoma. A Clinico-Pathological and Immunohistochemical Study of Seven Cases

E. Maiorano, M. Mastropasqua, G. Colella, 2020, Journal of clinical medicine.

P. Neven, G. Viale, M. Regan, 2007 .

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

G. Curigliano, R. Orecchia, M. Intra, 2012, Annals of Surgical Oncology.

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.

R. Gelber, A. Goldhirsch, G. Viale, 2012, Breast.

Positive axillary sentinel lymph node: is axillary dissection always necessary?

A. Luini, U. Veronesi, M. Intra, 2011, Breast.

Basaloid cell carcinoma of the prostate.

G. Pruneri, G. Viale, M. Mastropasqua, 2003, Virchows Archiv : an international journal of pathology.

Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series

G. Viale, G. Ingravallo, M. Mastropasqua, 2020, Breast.

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Anagha P. Jadhav, A. Gown, M. Ellis, 2022, Modern Pathology.

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

A. Giobbie-Hurder, R. Gelber, B. Gusterson, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression

G. Viale, H. Gobbi, M. Mastropasqua, 2015, Breast Cancer Research and Treatment.

Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma

S. Rizzo, M. Bellomi, M. Mastropasqua, 2004, European Radiology.

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.

F. Monti, B. Gusterson, A. Goldhirsch, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer subtypes and outcome after local and regional relapse.

A. Luini, A. Goldhirsch, G. Viale, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

A. Luini, A. Goldhirsch, G. Viale, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast

G. Viale, H. Gobbi, M. Mastropasqua, 2014, Breast Cancer Research and Treatment.

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

J. Forbes, R. Gelber, B. Gusterson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.